Abstract:Recent increase in the integration of nanotechnology and nanosciences to the biomedical sector fetches the human wellness through the development of sustainable treatment methodologies for cancerous tumors at all stages of their initiation and progression. This involves the development of multifunctional theranostic probes that effectively support for the early cancer diagnosis, avoiding non-target cell toxicity, controlled and customized anticancer drug release etc. Therefore, to advance the field of nanotechnology-based sustainable cancer treatment, we fabricated and tested the efficacy of anticancer drug-loaded magnetic hybrid nanoparticles (NPs) towards in vitro cell culture systems. The developed conjugate of NPs was incorporated with the functions of both controlled drug delivery and heat-releasing ability using Mn3O4 (manganese oxide) magnetic core with Cu shell encapsulated within trimethyl chitosan (TMC) biopolymer. On characterization, the Cu@Mn3O4-TMC NPs were confirmed to have an approximate size of 130 nm with full agglomeration (as observed by the HRTEM) and crystal size of 92.95 ± 18.38 nm with tetragonal hausmannite phase for Mn3O4 spinel structure (XRD). Also, the UV-Vis and FTIR analysis provided the qualitative and quantitative effects of 5-fluororacil (5-Fu) anticancer drug loading (max 68 %) onto the Cu@Mn3O4-TMC NPs. The DLS analysis indicated for the occurrence of no significant changes to the particle size (around 100 nm) of Cu@Mn3O4-TMC due to the solution dispersion thereby confirming for the aqueous stability of developed NPs. In addition, the magnetization values of Cu@Mn3O4-TMC NPs were measured to be 34 emu/g and a blocking temperature of 42 K. Further tests of magnetic hyperthermia by the Cu@Mn3O4-TMC/5-Fu NPs provided that the heat-releasing capacity (% ΔT at 15 min) increases with that of increased frequency, i.e. 28 % (440 Hz) > 22.6 % (240 Hz) > 18 % (44 Hz), and the highest specific power loss (SPL) value observed to be 488 W/g for water. Moreover, the 5-Fu drug release studies indicate that the release is high at a pH of 5.2 and almost all the loaded drug is getting delivered under the influence of the external magnetic field (430 Hz) due to the influence of both Brownian-rotation and Néel relaxation heat-mediated mechanism. The pharmacokinetic drug release studies have suggested for the occurrence of more than one model, i.e. First-order, Higuchi (diffusion), and Korsemeyer-Peppas (non-Fickian), in addition to hyperthermia. Finally, the in vitro cell culture systems (MCF-7 cancer and MCF-10 non-cancer) helped to differentiate the physiological changes due to the effects of hyperthermia and 5-Fu drug individually and as a combination of both. The observed differences of cell viability losses among both cell types are measured and discussed with the expression of heat shock proteins (HSPs) by the MCF-10 cells as against the MCF-7 cancer cells. We believe that the results generated in this project can be helpful for the designing of new cancer therapeutic models with nominal adverse effects on healthy normal cells and thus paving a way for the treatment of cancer and other deadly diseases in a sustainable manner.

Hyperthermia evaluation and drug/protein-controlled release using alternating magnetic field stimuli-responsive Mn–Zn ferrite composite particles

Magnetic Nanomaterials for Hyperthermia-Based Therapy, Imaging, and Drug Delivery

Magnetic Nanoparticle-Loaded Polymer Nanospheres As Magnetic Hyperthermia Agents

Smart composite hydrogel with magnetocaloric anisotropy for controllable multi-drug release

Biodegradable magnetic microspheres for drug targeting, temperature controlled drug release, and hyperthermia

Ferrimagnetic Mpeg-B-phep Copolymer Micelles Loaded with Iron Oxide Nanocubes and Emodin for Enhanced Magnetic Hyperthermia–chemotherapy

Experimental Evaluation on the Heating Efficiency of Magnetoferritin Nanoparticles in an Alternating Magnetic Field

Effect of manganese ion doping on magnetic properties and magnetic induction heating of Zn-Al ferrite nanoparticles

Biophysical Characterization of (Silica-coated) Cobalt Ferrite Nanoparticles for Hyperthermia Treatment

Over-hyperthermia using magnetic Fe nanoparticles

Shape‐Mediated Magnetocrystalline Anisotropy and Relaxation Controls by Cobalt Ferrite Core–Shell Heterostructures for Magnetothermal Penetration Delivery

Targeted Inductive Heating of Nanomagnets by a Combination of Alternating Current (AC) and Static Magnetic Fields

Preparation and characterization of Mn-Zn ferrite magnetic nanoparticles for tumor hyperthermia

Preparation and characterization of various PVPylated divalent metal-doped ferrite nanoparticles for magnetic hyperthermia

Evaluation of magnetic hyperthermia, drug delivery and biocompatibility (bone cell adhesion and zebrafish assays) of trace element co-doped hydroxyapatite combined with Mn-Zn ferrite for bone tissue applications

Magnetically controlled drug delivery and hyperthermia effects of core-shell Cu@Mn3O4 nanoparticles towards cancer cells in vitro

Iron oxide-loaded hollow mesoporous silica nanocapsules for controlled drug release and hyperthermia.

Investigation of the Application of Reduced Graphene Oxide-SPION Quantum Dots for Magnetic Hyperthermia

Fe-based nanoparticles as tunable magnetic particle hyperthermia agents

Synthesis and characterizations of magnetically inductive Mn–Zn spinel ferrite nanoparticles for hyperthermia applications

Heating effect and biocompatibility of bacterial magnetosomes as potential materials used in magnetic fluid hyperthermia